Assessing the Use of Anti-Pd1 Monotherapy As Adjuvant Therapy and Determinants of Treatment Choice in Stage III Cutaneous Melanoma in the US

Eric D. Whitman,Todor I. Totev, Shan Jiang, Wilson L. da Costa,Dmitri Grebennik, Hongjue Wang, Andra-Ecaterina Boca,Rajeev Ayyagari

BMC Cancer（2024）

Cited 0|Views9

No score

Key words

Adjuvant therapy,Stage III melanoma,Determinants of treatment choice

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined